Related references
Note: Only part of the references are listed.Systematic review: role of acid, weakly acidic and weakly alkaline reflux in gastro-oesophageal reflux disease
G. E. Boeckxstaens et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Arbaclofen Placarbil Decreases Postprandial Reflux in Patients With Gastroesophageal Reflux Disease
Lauren B. Gerson et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study
John Dent et al.
GUT (2010)
Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors
A. S. Raghunath et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Systematic review of endoscopic treatments for gastro-oesophageal reflux disease
D. Chen et al.
BRITISH JOURNAL OF SURGERY (2009)
Arbaclofen Placarbil, a Novel R-Baclofen Prodrug: Improved Absorption, Distribution, Metabolism, and Elimination Properties Compared with R-Baclofen
Ritu Lal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Clinical trial design in adult reflux disease: a methodological workshop
J. Dent et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring
I. Mainie et al.
GUT (2006)
The montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus
Nimish Vakil et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease - where next?
R Fass et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Effect of the GABAB agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors
GH Koek et al.
GUT (2003)
Effect of acute and chronic administration of the GABAB agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease
AF Ciccaglione et al.
GUT (2003)
The effect of baclofen on gastro-oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease
MA van Herwaarden et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Baclofen-mediated gastro-oesophageal acid reflux control in patients with established reflux disease
L Cange et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease
Q Zhang et al.
GUT (2002)
Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: Effect of omeprazole
MF Vela et al.
GASTROENTEROLOGY (2001)
Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects
I Lidums et al.
GASTROENTEROLOGY (2000)
Share Paper
